PUSH trial limits: why fluids still matter

The Lancet · Published 2026-07-30 · DOI 10.1016/s0140-6736(26)01030-5

Free full text

Authors (2)

Alba Martina Renzullo, Simone Benvenuto

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Renzullo, A., Benvenuto, S. (2026). PUSH trial limits: why fluids still matter. The Lancet. https://doi.org/10.1016/s0140-6736(26)01030-5

Related articles

• Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial · The Lancet · 2026 · Same journal
• David Rosner · The Lancet · 2026 · Same journal
• Rethinking anticoagulation intensity during extracorporeal membrane oxygenation · The Lancet · 2026 · Same journal
• [177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial · The Lancet · 2026 · Same journal
• Embracing neurodiversity in medicine: insights from the history of psychiatry · The Lancet · 2026 · Same journal
• Cambodia reaches HIV milestone · The Lancet · 2026 · Same journal
• Department of Error · The Lancet · 2026 · Same journal
• Learning from a decade of progress in amyloidosis · The Lancet · 2026 · Same journal
• Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies · The Lancet · 2026 · Same journal
• Judith Rapoport · The Lancet · 2026 · Same journal